SemBioSys Genetics Inc. and Tianjin Tasly Pharmaceutical Co. Ltd.
SemBioSys Genetics Inc. and Tianjin Tasly Pharmaceutical Co., Ltd. are signing supplementary documents necessary to establish the recently People’s Republic of China approved Joint Venture. The Joint Venture’s newly formed company based in Tianjin, China is called Tasly-SemBioSys Bio-Pharmaceutical Technology Co., Ltd. The new company will, on a global basis, commercialize near, medium, and long term healthy living, nutritional, and pharmaceutical products. It will utilize SemBioSys’ proprietary technology and research and development expertise, and Tasly’s research and development, product commercialization, marketing, and sales expertise.
SemBioSys Genetics Inc.与天津天士力制药有限公司将为其最近在中国获准成立的合资公司签署设立所需补充协议。该新近成立的合资公司，天力士胜宝生物制药科技有限公司注册在中国天津。合资公司将开发短，中，长期的健康营养产品及药品并在全球范围内商品化其开发的产品。合资公司将有效将SemBioSys的知识产权和研究开发能力与天士力的研究开发，产品商业化能力和其市场营销和销售能力相结合。